IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.189
NA - Nord America 4.554
AS - Asia 2.011
SA - Sud America 843
AF - Africa 414
OC - Oceania 5
Totale 13.016
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.461
US - Stati Uniti d'America 4.379
SG - Singapore 1.093
BR - Brasile 703
CI - Costa d'Avorio 339
VN - Vietnam 237
CN - Cina 194
HK - Hong Kong 154
IT - Italia 136
DE - Germania 119
GB - Regno Unito 98
CA - Canada 95
IN - India 71
AR - Argentina 58
NL - Olanda 52
MX - Messico 50
PL - Polonia 44
BD - Bangladesh 42
AT - Austria 34
CZ - Repubblica Ceca 32
IQ - Iraq 32
JP - Giappone 32
ZA - Sudafrica 32
ES - Italia 31
IE - Irlanda 29
LT - Lituania 29
FI - Finlandia 27
SE - Svezia 25
TR - Turchia 24
EC - Ecuador 22
ID - Indonesia 21
UA - Ucraina 20
PK - Pakistan 15
EG - Egitto 14
CO - Colombia 13
SA - Arabia Saudita 12
PY - Paraguay 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
FR - Francia 10
BE - Belgio 9
UZ - Uzbekistan 9
MA - Marocco 8
UY - Uruguay 8
PE - Perù 7
AZ - Azerbaigian 6
CL - Cile 6
JM - Giamaica 6
OM - Oman 6
AU - Australia 5
HN - Honduras 5
KE - Kenya 5
KR - Corea 5
NP - Nepal 5
PA - Panama 5
PH - Filippine 5
PT - Portogallo 5
AM - Armenia 4
BG - Bulgaria 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
GA - Gabon 3
HR - Croazia 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
RO - Romania 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 13.011
Salva come PNG Salva come JPEG
Città #
Dallas 2.628
Moscow 1.323
Singapore 510
Abidjan 339
Ashburn 271
New York 159
The Dalles 157
Hong Kong 149
Beijing 137
Los Angeles 113
Ho Chi Minh City 93
São Paulo 69
Amsterdam 44
Boardman 44
Hanoi 41
Brooklyn 39
Warsaw 39
Nuremberg 38
Santa Clara 38
Frankfurt am Main 34
Denver 32
Tokyo 32
Montreal 31
Assago 30
London 30
Munich 30
Chennai 29
Chicago 29
Dublin 27
Brno 26
Stockholm 25
Boston 24
Phoenix 24
San Francisco 24
Rio de Janeiro 22
Johannesburg 21
Toronto 21
Atlanta 17
Belo Horizonte 16
Ankara 15
Columbus 15
Mexico City 15
Council Bluffs 14
Da Nang 14
West Jordan 14
Baghdad 12
Helsinki 12
Ottawa 12
Brasília 11
Charlotte 11
Guarulhos 11
Haiphong 11
Houston 11
Poplar 11
Querétaro 11
Volta Redonda 11
Falkenstein 10
Orem 10
Brussels 9
Córdoba 9
Goiânia 9
Lahore 9
Mumbai 9
Rome 9
Tashkent 9
Vienna 9
Curitiba 8
Ha Long 8
Jakarta 8
Lappeenranta 8
Manchester 8
Santo André 8
Terzigno 8
Montevideo 7
New Delhi 7
Sumaré 7
Turku 7
Baku 6
Damietta 6
Guayaquil 6
Las Vegas 6
Milan 6
Orlando 6
Quito 6
Ribeirão Preto 6
Salvador 6
Seeb 6
São Bernardo do Campo 6
São José dos Campos 6
Vilnius 6
Acerra 5
Camaçari 5
Ezeiza 5
Fortaleza 5
Helena 5
Kingston 5
Lima 5
Naples 5
Olomouc 5
Porto Alegre 5
Totale 7.270
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 591
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 522
A genic and epigenetic combination therapy for liver cancer 112
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 108
A suspected infective endocarditis in patients with a history of chronic HCV infection 105
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 105
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 99
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 96
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 95
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 95
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 95
Advances in Nanomedicine for Precision Insulin Delivery 95
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 93
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 91
[Next Generation Sequencing and ADPKD] 90
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 90
A gene and epigenetic combination therapy for liver cancer treatment 89
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 86
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 85
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 84
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 84
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 84
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 83
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 83
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 83
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 83
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 83
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 82
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 82
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 80
Antibiotic use and associated factors in a large sample of hospitalised older people 80
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 79
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 78
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 76
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 76
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 75
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 75
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 71
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 70
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 68
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 67
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 65
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 65
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 64
HCV-related steatosis and risk of atherosclerosis 64
Cardiovascular benefits from gliflozins: Effects on endothelial function 63
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 63
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 63
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 62
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 57
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 56
What changed in the Italian internal medicine and geriatric wards during the lockdown 55
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 54
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 54
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 52
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 51
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 51
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 49
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 49
Sonoporation by microbubbles as gene therapy approach for liver cancer 49
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 48
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 48
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study. Authors’ reply 48
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 47
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 47
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 46
HCV-related steatosis and risk of atherosclerosis 46
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 45
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 44
Insulin resistance and cancer: molecular links and clinical perspectives 44
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 44
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 44
Lactate in pleural and abdominal effusions 43
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 43
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 43
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 42
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 41
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 41
Antioxidant diet and genotyping as tools for the prevention of liver disease 41
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 41
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 41
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 41
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 41
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 39
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 39
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 39
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? 39
HCC recurrence after DAA treatment in HCV patients 39
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 39
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 38
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 38
Editorial: Tissue resonance interaction method: a challenge for the early and non-invasive diagnosis of solid cancers 38
Metformin: An old drug against old age and associated morbidities 38
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 38
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 38
Metabolic and renal changes in chronic hepatitis C patients after HCV clearance by direct-acting antivirals 38
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 38
L'indagine medico-nucleare dei tumori del pancreas endocrino 38
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: incidence, characteristics, risk factors and survival 38
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 37
Totale 7.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20253.369 520 223 254 23 416 66 112 121 453 74 490 617
2025/20269.358 530 1.404 1.774 735 3.353 1.562 0 0 0 0 0 0
Totale 13.061